Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Development of an Algorithm for Identification of Responders to Short Term Treatment With Esomeprazole (Nexium) in Primary Care

NCT00318968 is registered in ClinicalTrials.gov with AstraZeneca as lead sponsor.

NCT NCT00318968
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00318968 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Development of an Algorithm for Identification of Responders to Short Term Treatment With Esomeprazole (Nexium) in Primary Care
Lead sponsor
AstraZeneca
Phase
Phase 4
Overall status
Completed
Start date
May 31, 2006
Completion date
November 30, 2007
Enrollment
1,000 (estimated)
Sites
38

Conditions

As the registry lists them; a condition with its own page is linked.

gerd